175 related articles for article (PubMed ID: 19664568)
21. Lower aspirin doses in dual antiplatelet therapy optimise efficacy and safety: CHARISMA follow-up study.
Cardiovasc J Afr; 2009; 20(3):205. PubMed ID: 19575092
[No Abstract] [Full Text] [Related]
22. Bleeding complications with dual antiplatelet therapy among patients with stable vascular disease or risk factors for vascular disease: results from the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial.
Berger PB; Bhatt DL; Fuster V; Steg PG; Fox KA; Shao M; Brennan DM; Hacke W; Montalescot G; Steinhubl SR; Topol EJ;
Circulation; 2010 Jun; 121(23):2575-83. PubMed ID: 20516378
[TBL] [Abstract][Full Text] [Related]
23. Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial.
Fox KA; Mehta SR; Peters R; Zhao F; Lakkis N; Gersh BJ; Yusuf S;
Circulation; 2004 Sep; 110(10):1202-8. PubMed ID: 15313956
[TBL] [Abstract][Full Text] [Related]
24. Clopidogrel is associated with better in-hospital and 30-day outcomes than ticlopidine after coronary stenting.
L'Allier PL; Aronow HD; Cura FA; Bhatt DL; Albirini A; Schneider JP; Topol EJ; Ellis SG
Can J Cardiol; 2003 Aug; 19(9):1041-6. PubMed ID: 12915931
[TBL] [Abstract][Full Text] [Related]
25. Dual oral antiplatelet therapy and unplanned surgery: possible role for intravenous platelet glycoprotein receptor inhibitors.
Bollati M; Giraudi E; Moretti C; Millesimo G; Sciuto F; Omedè P; Biondi Zoccai G; Sheiban I
J Cardiovasc Med (Hagerstown); 2011 Sep; 12(9):673-4. PubMed ID: 21796059
[No Abstract] [Full Text] [Related]
26. Antiplatelet therapy discontinuation following drug-eluting stent placement: dangers, reasons, and management recommendations.
Moussa ID; Colombo A
Catheter Cardiovasc Interv; 2009 Dec; 74(7):1047-54. PubMed ID: 19626692
[TBL] [Abstract][Full Text] [Related]
27. Clopidogrel: who, when, and how?
Cannon CP
Rev Cardiovasc Med; 2007; 8 Suppl 3():S27-34. PubMed ID: 17917618
[TBL] [Abstract][Full Text] [Related]
28. Early and late benefits of prasugrel in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a TRITON-TIMI 38 (TRial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet InhibitioN with Prasugrel-Thrombolysis In Myocardial Infarction) analysis.
Antman EM; Wiviott SD; Murphy SA; Voitk J; Hasin Y; Widimsky P; Chandna H; Macias W; McCabe CH; Braunwald E
J Am Coll Cardiol; 2008 May; 51(21):2028-33. PubMed ID: 18498956
[TBL] [Abstract][Full Text] [Related]
29. Clinical outcomes in patients with the concomitant use of clopidogrel and proton pump inhibitors after percutaneous coronary intervention: an analysis from the Guthrie Health Off-Label Stent (GHOST) investigators.
Harjai KJ; Shenoy C; Orshaw P; Usmani S; Boura J; Mehta RH
Circ Cardiovasc Interv; 2011 Apr; 4(2):162-70. PubMed ID: 21386091
[TBL] [Abstract][Full Text] [Related]
30. Acknowledging a failed strategy.
Bass TA
Catheter Cardiovasc Interv; 2009 Jun; 73(7):871-3. PubMed ID: 19455650
[No Abstract] [Full Text] [Related]
31. The safety of clopidogrel.
Mangalpally KK; Kleiman NS
Expert Opin Drug Saf; 2011 Jan; 10(1):85-95. PubMed ID: 21091040
[TBL] [Abstract][Full Text] [Related]
32. Randomised controlled trial evaluating the role of tirofiban in high-risk non-ST elevation acute coronary syndromes: an East Indian perspective.
Bhattacharya R; Pani A; Dutta D; Basak S; Gangopadhyay S; Das Baksi S; Sarkar RN
Singapore Med J; 2010 Jul; 51(7):558-64. PubMed ID: 20730395
[TBL] [Abstract][Full Text] [Related]
33. Comparison of the impact of short (<1 year) and long-term (> or =1 year) clopidogrel use following percutaneous coronary intervention on mortality.
Banerjee S; Varghese C; Samuel J; Weideman RA; Little BB; Kelly KC; Rao SV; Reilly RF; Brilakis ES
Am J Cardiol; 2008 Nov; 102(9):1159-62. PubMed ID: 18940284
[TBL] [Abstract][Full Text] [Related]
34. Prasugrel in the poststroke cohort of the TRITON Trial: the clear and present danger.
Serebruany VL; Alberts MJ; Hanley DF
Cerebrovasc Dis; 2008; 26(1):93-4. PubMed ID: 18547948
[No Abstract] [Full Text] [Related]
35. Antiplatelet therapy in the perioperative period.
Václavík J; Táborský M
Eur J Intern Med; 2011 Feb; 22(1):26-31. PubMed ID: 21238889
[TBL] [Abstract][Full Text] [Related]
36. Comparison of ticagrelor, the first reversible oral P2Y(12) receptor antagonist, with clopidogrel in patients with acute coronary syndromes: Rationale, design, and baseline characteristics of the PLATelet inhibition and patient Outcomes (PLATO) trial.
James S; Akerblom A; Cannon CP; Emanuelsson H; Husted S; Katus H; Skene A; Steg PG; Storey RF; Harrington R; Becker R; Wallentin L
Am Heart J; 2009 Apr; 157(4):599-605. PubMed ID: 19332184
[TBL] [Abstract][Full Text] [Related]
37. Impact of proton pump inhibitors on the effectiveness of clopidogrel after coronary stent placement: the clopidogrel Medco outcomes study.
Kreutz RP; Stanek EJ; Aubert R; Yao J; Breall JA; Desta Z; Skaar TC; Teagarden JR; Frueh FW; Epstein RS; Flockhart DA
Pharmacotherapy; 2010 Aug; 30(8):787-96. PubMed ID: 20653354
[TBL] [Abstract][Full Text] [Related]
38. Aspirin combined with clopidogrel (Plavix) decreases cardiovascular events in patients with acute coronary syndrome.
Walker CW; Dawley CA; Fletcher SF
Am Fam Physician; 2007 Dec; 76(11):1643-5. PubMed ID: 18092705
[No Abstract] [Full Text] [Related]
39. Conversation with an expert. Plavix: what you need to know.
O'Gara P
Harv Heart Lett; 2011 Jan; 21(5):3. PubMed ID: 21322911
[No Abstract] [Full Text] [Related]
40. A randomised determination of the Effect of Fluvastatin and Atorvastatin on top of dual antiplatelet treatment on platelet aggregation after implantation of coronary drug-eluting stents. The EFA-Trial.
Wenaweser P; Eshtehardi P; Abrecht L; Zwahlen M; Schmidlin K; Windecker S; Meier B; Haeberli A; Hess OM
Thromb Haemost; 2010 Sep; 104(3):554-62. PubMed ID: 20664903
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
